產(chǎn)品描述: | ARN2966 is an inhibitor of amyloid precursor protein (APP)and amyloid-β (Aβ) secretion. |
靶點(diǎn): |
Beta Amyloid;BetaAmyloid |
體外研究: |
ARN2966 reduces levels of APP and its intracellular C-terminal fragments α-CTF and β-CTF in CHO APP751SW cells when used at a concentration of 10 μM. ARN2966?also reduces?secretion of Aβ (1-40) and Aβ (1-42) by 88.6 and 84.9%, respectively. |
體內(nèi)研究: |
In vivo,ARN2966? reduces brain levels of full-length APP, α-CTF and β-CTF, and soluble Aβ (1-40) and Aβ (1-42) in the APPSWPS1dE9 transgenic mouse model of Alzheimer's disease.It also improves novel object memory as well as spatial memory in the radial arm maze in APPSWPS1dE9 transgenic mice. |
參考文獻(xiàn): |
1. Asuni A A . Modulation of APP Expression Reduces Aβ Deposition in a Mouse Model.[J]. Annals of Neurology, 2014, 75(5):684. |
溶解性: |
soluble in DMSO |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
4.994 ml |
24.97 ml |
49.941 ml |
5 mM |
0.999 ml |
4.994 ml |
9.988 ml |
10 mM |
0.499 ml |
2.497 ml |
4.994 ml |
50 mM |
0.1 ml |
0.499 ml |
0.999 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |